Johnson & Johnson has filed a lawsuit seeking validation of its rebate model for 340B drugs, which offers post-sale rebates instead of upfront discounts. The initiative, criticized by hospitals and ...

Zai Lab has priced its public offering at $25.50 per share, targeting $200 million for corporate purposes. The fundraising ...

The MHRA has approved Novavax’s updated Nuvaxovid vaccine for the latest subvariant in individuals aged 12 and older. This ...

South Korean biosimilars company Celltrion today announced its acquisition of iQone Healthcare Switzerland a specialty ...

The European Medicines Agency’s (EMA) human medicines committee (CHMP) made a number of recommendations at its November ...